A Large-Diameter Thrombus Retrieving Device for Intermediate-Risk Acute Pulmonary Embolism Treatment: A Single-Arm Prospective Clinical Trial

What is the clinical question being addressed? How can acute pulmonary embolism be treated more safely and effectively?What is the main finding?Treating intermediate-risk patients with acute pulmonary embolism with a large-diameter thrombus aspiration and mechanical thrombectomy device may have acceptable clinical benefits.Globally, acute pulmonary embolism (PE) is the third leading cause of cardiovascular-related deaths after myocardial infarction and stroke [1].Several studies have reported increased annual incidence of PE and consequently social medical burden [2].Determining how to treat acute PE more safely and effectively, while decreasing long-term complications, remains an important issue in medicine.The aim of this study was to report the results of a single-arm clinical trial in intermediate-risk patients with acute PE treated with a device for large-diameter thrombus aspiration (16 F or greater) and mechanical thrombectomy.This prospective, single-arm clinical trial was conducted between March 2022 and January 2023 at Xiamen Cardiovascular Hospital, Xiamen University, China.The clinical trial was registered at http://clinicaltrials.gov (Clinical Trial ID: NCT 05443919).A comprehensive description of the study design, data collection methods, inclusion and exclusion criteria, and outcome measure can be found at https://clinicaltrials.gov/ study/NCT05443919.PE severity was evaluated in accordance with the scoring criteria outlined in the ESC acute PE guidelines [2], and patients with intermediate-risk acute PE were included in the study.All 13 patients (average age: 66.85 y) were treated with the device consisting of thrombus aspiration and pulmonary artery retrieval systems (Figure 1).Most patients were women (n = 8, 61.54%).The median PE severity index score at admission was 102 (interquartile range, IQR: 73-106).Ten patients presented with bilateral PE.Table 1 provides a detailed summary of the perioperative

Authors

Publication Details

Journal
Cardiovascular Innovations and Applications
Published
2024-12-31
DOI
https://doi.org/10.15212/cvia.2024.0055
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Large-Diameter Thrombus Retrieving Device for Intermediate-Risk Acute Pulmonary Embolism Treatment: A Single-Arm Prospective Clinical Trial

Yan Wang, Sun Hu, Yang Li, Xuwei Shen et al.
Cardiovascular Innovations and Applications
Venous Thromboembolism Diagnosis and Management
article

A Large-Diameter Thrombus Retrieving Device for Intermediate-Risk Acute Pulmonary Embolism Treatment: A Single-Arm Prospective Clinical Trial

Yan Wang, Sun Hu, Yang Li, Xuwei Shen, Yuchen Liang, Hui Zhuang
article en

Abstract

What is the clinical question being addressed? How can acute pulmonary embolism be treated more safely and effectively?What is the main finding?Treating intermediate-risk patients with acute pulmonary embolism with a large-diameter thrombus aspiration and mechanical thrombectomy device may have acceptable clinical benefits.Globally, acute pulmonary embolism (PE) is the third leading cause of cardiovascular-related deaths after myocardial infarction and stroke [1].Several studies have reported increased annual incidence of PE and consequently social medical burden [2].Determining how to treat acute PE more safely and effectively, while decreasing long-term complications, remains an important issue in medicine.The aim of this study was to report the results of a single-arm clinical trial in intermediate-risk patients with acute PE treated with a device for large-diameter thrombus aspiration (16 F or greater) and mechanical thrombectomy.This prospective, single-arm clinical trial was conducted between March 2022 and January 2023 at Xiamen Cardiovascular Hospital, Xiamen University, China.The clinical trial was registered at http://clinicaltrials.gov (Clinical Trial ID: NCT 05443919).A comprehensive description of the study design, data collection methods, inclusion and exclusion criteria, and outcome measure can be found at https://clinicaltrials.gov/ study/NCT05443919.PE severity was evaluated in accordance with the scoring criteria outlined in the ESC acute PE guidelines [2], and patients with intermediate-risk acute PE were included in the study.All 13 patients (average age: 66.85 y) were treated with the device consisting of thrombus aspiration and pulmonary artery retrieval systems (Figure 1).Most patients were women (n = 8, 61.54%).The median PE severity index score at admission was 102 (interquartile range, IQR: 73-106).Ten patients presented with bilateral PE.Table 1 provides a detailed summary of the perioperative

Cardiovascular Innovations and ApplicationsVol. 10(1)
Openalex Percentile: Top 51%
Venous Thromboembolism Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Large-Diameter Thrombus Retrieving Device for Intermediate-Risk Acute Pulmonary Embolism Treatment: A Single-Arm Prospective Clinical Trial — Yan Wang, Sun Hu, et al. · Cardiovascular Innovations and Applications (2024) | TGRS Research Map | TGRS